Ignite Creation Date:
2025-12-24 @ 1:09 PM
Ignite Modification Date:
2025-12-28 @ 5:09 PM
Study NCT ID:
NCT04835961
Status:
COMPLETED
Last Update Posted:
2023-11-01
First Post:
2021-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice.
Sponsor:
Elpen Pharmaceutical Co. Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-02
First Submit QC Date:
None
Study First Post Date:
2021-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-31
Last Update Post Date:
2023-11-01
Last Update Post Date Type:
ACTUAL